Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arteris, Inc. Director's Dealing 2023

Dec 5, 2023

32988_dirs_2023-12-05_a89efd6d-a629-4233-825a-4192b1f1ae14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arteris, Inc. (AIP)
CIK: 0001667011
Period of Report: 2023-12-01

Reporting Person: Alpern Paul L (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-01 Common Stock M 1250.00 $0.60 Acquired 42126.00 Direct
2023-12-01 Common Stock M 10000.00 $0.56 Acquired 52126.00 Direct
2023-12-01 Common Stock S 1250.00 $5.46 Disposed 50876.00 Direct
2023-12-01 Common Stock S 10000.00 $5.5411 Disposed 40876.00 Direct
2023-12-04 Common Stock S 251.00 $5.3269 Disposed 40625.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-12-01 Common Stock $0.60 M 1250.00 Disposed 2030-07-22 Common Stock (1250.00) Direct
2023-12-01 Common Stock $0.56 M 10000.00 Disposed 2029-10-23 Common Stock (10000.00) Direct

Footnotes

F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on August 16 2023.

F2: 25% of the total shares vested on July 23, 2021; thereafter, 1/48th of the total shares vest monthly for 3 years. beginning on August 23, 2021.

F3: 25% of the total shares vested on August 26, 2020; thereafter, 1/48th of the total shares have vested monthly for 3 years. beginning on September 26, 2020.

F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $5.28 to $5.79 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.

F6: Includes 40,193 restricted stock units.